KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Ionis Pharmaceuticals (IONS) over the last 17 years, with Q3 2025 value amounting to 0.2.

  • Ionis Pharmaceuticals' Equity Ratio fell 524.1% to 0.2 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.2, marking a year-over-year decrease of 524.1%. This contributed to the annual value of 0.2 for FY2024, which is 5146.31% up from last year.
  • Per Ionis Pharmaceuticals' latest filing, its Equity Ratio stood at 0.2 for Q3 2025, which was down 524.1% from 0.21 recorded in Q2 2025.
  • Ionis Pharmaceuticals' 5-year Equity Ratio high stood at 0.3 for Q1 2021, and its period low was 0.1 during Q2 2024.
  • For the 5-year period, Ionis Pharmaceuticals' Equity Ratio averaged around 0.2, with its median value being 0.21 (2025).
  • In the last 5 years, Ionis Pharmaceuticals' Equity Ratio tumbled by 5766.24% in 2021 and then soared by 11596.89% in 2025.
  • Over the past 5 years, Ionis Pharmaceuticals' Equity Ratio (Quarter) stood at 0.3 in 2021, then decreased by 23.49% to 0.23 in 2022, then crashed by 42.8% to 0.13 in 2023, then soared by 51.46% to 0.2 in 2024, then increased by 4.02% to 0.2 in 2025.
  • Its Equity Ratio was 0.2 in Q3 2025, compared to 0.21 in Q2 2025 and 0.17 in Q1 2025.